The risk of altitude decompression sickness at 12,000 m and the effect of ascent rate

Aviation Space and Environmental Medicine

Volumn 74, Issue 10, 2003, Pages 1052-1057

  Pilmanis, Andrew A ^a   Webb, James T ^b   Kannan, Nandini ^c   Balldin, Ulf I ^b  

^a AIR FORCE RESEARCH LABORATORY   (United States)

^b WYLE LABORATORIES   (United States)

^c UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

Altitude; Decompression rate; Decompression sickness; Venous gas emboli

Indexed keywords

ADULT; AIRCRAFT; ALTITUDE; ALTITUDE DISEASE; ARTICLE; DECOMPRESSION; DECOMPRESSION SICKNESS; FEMALE; GAS EMBOLISM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESSURE; RISK FACTOR;

NON-PROGRAMMATIC;

ADULT; AIRCRAFT; ALTITUDE; DECOMPRESSION SICKNESS; EMBOLISM, AIR; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0141678991     PISSN: 00956562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Balldin UI, Pilmanis AA, Webb JT. Pulmonary decompression sickness at altitude: early symptoms and circulating gas emboli. Aviat Space Environ Med 2002; 73:996-9.
2. Clarke RW, Humm FD, Nims LF. The efficacy of preflight denitrogenation in the prevention of decompression sickness. Washington, DC: National Research Council, Comittee on Aviation Medicine; 1945. CAM Report #472.
3. Cook SF, Williams OL, Lyons WR, Lawrence JH. A comparison of altitude and exercise with respect to decompression sickness. War Medicine 1944; 6:182-7.
4. DeHart RL, Ed. Fundamentals of aerospace medicine, 2nd ed. Baltimore, MD: Williams & Wilkins, 1996.
5. Fraser AM, Stewart CB, Manning GW. Review of Canadian investigations on decompression sickness. Washington, DC: National Research Council, Comittee on Aviation Medicine; 1943. CAM Report #C-2503.
6. Gibbons J, Ramsey CS, Wright JK, Pilmanis AA. Serious altitude decompression sickness following rapid rate of ascent. Aviat Space Environ Med 2003; 74:675-9.
7. Gillies JA, ed. A textbook of aviation physiology. Oxford: Pergamon Press; 1965:133.
8. Gray JS. Certain advantages of a simulated flight at 38,000 ft for high altitude classification. Brooks AFB, TX: USAF School of Aerospace Medicine; 1942. SAM Report, Project #14.
9. Gray JS. Present status of the problem of decompression sickness. Brooks AFB, TX: USAF School of Aerospace Medicine; 1944. SAM Report, Project #458.
10. Griffin DR, Robinson S, Belding HS, et al. The effects of cold and rate of ascent on aeroembolism. Washington, DC: National Research Council, Comittee on Aviation Medicine; 1943. CAM Report #174.
11. Ikels KG. Production of gas bubbles in fluids by tribonucleation. J Appl Physiol 1970; 28:524-7.
12. Kumar KV, Waligora JM. The effects of different rates of ascent on the incidence of altitude decompression sickness. Houston, TX: NASA 1989. TM 100472.
13. Nims LF. Environmental factors affecting decompression sickness, Part I. A physical theory of decompression sickness. In: Fulton JF, ed. Decompression sickness, Chapter VIII. Philadelphia: W.B. Saunders Co.; 1951:192.
14. Pilmanis AA, Olson RM, Fischer MD, et al. Exercise-induced altitude decompression sickness. Aviat Space Environ Med 1999; 70:22-9.
15. Pilmanis AA, Stegmann BJ. Decompression sickness and ebullism at high altitudes. In: High altitude and high acceleration protection for military aircrew. Proceedings of the NATO AGARD Symposium 71st Aerospace Medical Panel. Pensacola, FL. Neuilly-sur-Seine, France: NATO; 1991; AGARD-CP-516.
16. Spencer MP. Decompression limits for compressed air determined by ultrasonically detected blood bubbles. J Appl Physiol 1976; 40:229-35.
17. Stewart CB, Smith HW. A comparison of the incidence of decompression sickness at 35,000 and 40,000 feet. Washington, DC: National Research Council, Committee on Aviation Medicine; 1945. CAM Report #C-3050.
18. Vavala DA. The present status of aeroembolism. J Aviat Med 1955; 26:230-9.
19. Webb JT, Krause KM, Pilmanis AA, et al. The effect of exposure to 35,000 ft on incidence of altitude decompression sickness. Aviat Space Environ Med 2001; 72:509-12.